BLUEGNOME LIMITED

CB22 5LD (East of England)

Start Date End Date

Funded Value Relevance

CSV

25 50 100

£223,964

Aug 08 - Sep 10

Diagnosis and treatment of haematological cancers with a single, point of care microarray test (Haemarray).

Innovate UK award to BLUEGNOME LIMITED

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}